-
MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says
Tuesday, August 30, 2016 - 3:50pm | 310Biopharmaceutical company MannKind Corporation (NASDAQ: MNKD) is "making progress" in developing a less costly alternative to Mylan NV (NASDAQ: MYL)'s EpiPen. According to Connecticut-based News Times, MannKind's local manufacturing facility employs around 150 people in the city and plays a key...